PALI — PALISADE BIO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 129 SEC-registered investment managers reported holding PALI (PALISADE BIO INC) in their latest 13F filings, with a combined reported value of $376.61M across 180.30M shares. That is +8.4% by share count (+11.29M shares) versus the previous quarter, while reported value moved +29.5%. Ownership is concentrated: the five largest holders account for 31.5% of reported value and the top ten for 51.9%.
Compared with the prior quarter, 54 opened new positions, 34 added to existing stakes, 25 trimmed, 23 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of PALISADE BIO INC (PALI) include Soleus Capital Management, L.P., B Group, Inc., AMERIPRISE FINANCIAL INC, ranked by reported 13F value among the 188 institutional holders on this page.
PALI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 70 | 55.71M | $74.62M | +20.2% |
| Q2 2026 | 129 | 180.30M | $376.61M | +8.4% |
| Q1 2026 | 98 | 154.57M | $270.62M | +5.6% |
| Q4 2025 | 88 | 137.75M | $320.06M | +6681.9% |
| Q3 2025 | 12 | 119.59K | $102.82K | +39.6% |
| Q2 2025 | 11 | 84.61K | $57.54K | -44.4% |
| Q1 2025 | 13 | 296.36K | $200.95K | +50.7% |
| Q4 2024 | 10 | 234.98K | $387.72K | +72.8% |
Over the 8 quarters shown, institutional share counts increased 23607% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+6681.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.10M | $14.98M | 0.00% | Add | |
| 7.89M | $10.65M | 0.00% | Add | |
| 6.07M | $7.59M | 0.00% | Add | |
| 3.86M | $5.21M | 0.00% | Add | |
| 3.14M | $4.23M | 0.01% | Hold | |
| 2.93M | $3.96M | 0.00% | Add | |
| 2.34M | $3.15M | 0.40% | New | |
| 2.28M | $3.07M | 0.00% | Add | |
| 2.22M | $3.00M | 1.59% | Reduce | |
| 2.13M | $2.88M | 0.01% | Add | |
| 2.00M | $2.70M | 0.06% | Hold | |
| 1.44M | $1.95M | 0.00% | Add | |
| 1.15M | $1.55M | 0.41% | Reduce | |
| 1.12M | $1.51M | 0.00% | Add | |
| 1.08M | $1.46M | 0.00% | Add | |
| 680.00K | $918.00K | 0.35% | Add | |
| 679.00K | $916.65K | 0.04% | Add | |
| 524.64K | $708.26K | 0.00% | Reduce | |
| 434.33K | $586.35K | 0.01% | Reduce | |
| 368.42K | $497.36K | 0.00% | Add | |
| 307.50K | $415.12K | 0.28% | New | |
| 205.88K | $277.94K | 0.00% | Add | |
| 172.44K | $232.79K | 0.00% | Add | |
| 138.95K | $187.59K | 0.07% | Add | |
| 125.92K | $170.00K | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.06M | $27.30M | 0.94% | New | |
| 11.41M | $23.86M | 11.20% | Hold | |
| 11.08M | $23.16M | 0.01% | Reduce | |
| 10.69M | $22.39M | 0.01% | New | |
| 10.44M | $21.81M | 0.00% | Add | |
| 10.28M | $21.48M | 1.93% | Hold | |
| 8.43M | $17.61M | 0.28% | Reduce | |
| 7.12M | $14.89M | 0.13% | Hold | |
| 5.79M | $12.09M | 0.00% | Hold | |
| 5.25M | $10.98M | 0.04% | Add | |
| 4.80M | $10.03M | 0.76% | Hold | |
| 4.50M | $9.40M | 0.01% | Hold | |
| 4.18M | $8.74M | 0.46% | Reduce | |
| 3.76M | $7.86M | 0.00% | New | |
| 3.76M | $7.86M | 0.00% | Add | |
| 3.70M | $7.74M | 0.00% | Add | |
| 3.70M | $7.74M | 0.00% | Add | |
| 3.58M | $7.48M | 0.00% | Reduce | |
| 3.14M | $6.56M | 0.01% | Hold | |
| 3.00M | $6.27M | 2.45% | Hold | |
| 2.58M | $5.40M | 2.82% | Add | |
| 2.50M | $5.22M | 0.12% | Hold | |
| 2.47M | $5.17M | 0.00% | Reduce | |
| 2.33M | $4.88M | 0.10% | Hold | |
| 2.28M | $4.78M | 1.00% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.51M | $20.14M | 0.01% | Add | |
| 11.41M | $19.97M | 14.81% | Add | |
| 10.69M | $18.76M | 0.01% | Add | |
| 10.28M | $17.98M | 1.99% | Add | |
| 8.93M | $15.62M | 0.33% | Reduce | |
| 7.18M | $12.57M | 0.73% | Reduce | |
| 7.12M | $12.47M | 0.13% | Hold | |
| 5.79M | $10.12M | 0.00% | Add | |
| 5.37M | $9.40M | 0.00% | Add | |
| 4.99M | $8.73M | 0.47% | Reduce | |
| 4.80M | $8.40M | 1.10% | Hold | |
| 4.55M | $7.97M | 0.00% | Add | |
| 4.50M | $7.88M | 0.01% | Hold | |
| 3.41M | $5.96M | 1.37% | New | |
| 3.27M | $5.72M | 0.02% | Add | |
| 3.14M | $5.49M | 0.01% | New | |
| 3.00M | $5.25M | 2.25% | Reduce | |
| 2.90M | $5.08M | 0.00% | New | |
| 2.90M | $5.08M | 0.00% | New | |
| 2.75M | $4.82M | 0.01% | New | |
| 2.50M | $4.38M | 0.12% | New | |
| 2.33M | $4.08M | 0.08% | Add | |
| 2.26M | $3.96M | 0.27% | Add | |
| 2.10M | $3.68M | 0.00% | Add | |
| 2.10M | $3.68M | 0.01% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.05M | $28.32M | 0.54% | New | |
| 11.45M | $26.90M | 1.79% | New | |
| 10.54M | $24.82M | 0.01% | New | |
| 10.50M | $24.66M | 0.09% | New | |
| 9.57M | $22.48M | 2.73% | New | |
| 7.12M | $16.74M | 0.17% | New | |
| 6.91M | $16.24M | 0.00% | New | |
| 5.39M | $12.67M | 0.64% | New | |
| 5.09M | $11.97M | 0.00% | New | |
| 4.80M | $11.28M | 2.47% | New | |
| 4.50M | $10.57M | 0.02% | New | |
| 4.50M | $10.57M | 7.81% | New | |
| 4.50M | $10.57M | 4.48% | New | |
| 4.19M | $9.85M | 1.91% | New | |
| 4.14M | $9.73M | 0.00% | Add | |
| 2.38M | $5.60M | 0.01% | New | |
| 2.29M | $5.39M | 0.35% | New | |
| 2.12M | $4.97M | 0.00% | New | |
| 2.00M | $4.71M | 0.37% | New | |
| 1.99M | $4.68M | 1.03% | New | |
| 1.88M | $4.42M | 0.00% | New | |
| 1.87M | $4.40M | 0.09% | New | |
| 1.70M | $4.00M | 0.01% | New | |
| 1.58M | $3.71M | 0.00% | New | |
| 1.57M | $3.68M | 0.00% | Add |
Q3 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29.41K | $25.28K | 0.00% | Add | |
| 26.62K | $22.88K | 0.00% | Add | |
| 19.41K | $16.70K | 0.00% | Add | |
| 14.09K | $12.11K | 0.00% | Reduce | |
| 13.00K | $11.18K | 0.00% | Add | |
| 8.62K | $7.41K | 0.00% | Add | |
| 5.40K | $4.64K | 0.00% | Add | |
| 2.35K | $2.02K | 0.00% | New | |
| 500 | $430 | 0.00% | New | |
| 100 | $86 | 0.00% | Hold | |
| 86 | $73 | 0.00% | Add | |
| 21 | $18 | 0.00% | Hold |
Q2 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.34K | $18.59K | 0.00% | New | |
| 24.73K | $16.82K | 0.00% | Hold | |
| 15.97K | $10.86K | 0.00% | Add | |
| 10.50K | $7.14K | 0.00% | New | |
| 4.57K | $3.11K | 0.00% | Hold | |
| 1.00K | $680 | 0.00% | New | |
| 332 | $226 | 0.00% | Reduce | |
| 100 | $68 | 0.00% | Hold | |
| 45 | $31 | 0.00% | Add | |
| 21 | $14 | 0.00% | Hold | |
| 7 | $5 | 0.00% | Reduce |
New Positions (Q2 2026)
- Soleus Capital Management, L.P. 13.06M sh · $27.30M
- Jupiter Topco LLC 10.69M sh · $22.39M
- GEODE CAPITAL MANAGEMENT, LLC 3.76M sh · $7.86M
- Siren, L.L.C. 2.00M sh · $4.18M
- Ally Bridge Group (NY) LLC 1.23M sh · $2.57M
- VANGUARD PORTFOLIO MANAGEMENT LLC 994.10K sh · $2.08M
- Nuveen, LLC 969.46K sh · $2.03M
- Sixth Street Partners Management Company, L.P. 434.98K sh · $909.11K
- Virtu Financial LLC 167.16K sh · $349.00K
- RHUMBLINE ADVISERS 160.77K sh · $336.01K
- Deutsche Bank AG 144.00K sh · $300.96K
- Wells Fargo & Co 125.57K sh · $262.44K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 10.69M sh · $18.76M
- Commodore Capital LP sold 7.18M sh · $12.57M
- STATE STREET CORP sold 636.20K sh · $1.11M
- Exome Asset Management LLC sold 600.00K sh · $1.05M
- JANE STREET GROUP, LLC sold 410.76K sh · $718.83K
- Brevan Howard Capital Management LP sold 214.82K sh · $375.94K
- HRT FINANCIAL LP sold 211.88K sh · $370.00K
- Qube Research & Technologies Ltd sold 148.97K sh · $260.70K
- PRELUDE CAPITAL MANAGEMENT, LLC sold 133.13K sh · $232.98K
- Graham Capital Management, L.P. sold 105.83K sh · $185.21K
- Hudson Bay Capital Management LP sold 89.39K sh · $156.43K
- OMERS ADMINISTRATION Corp sold 83.30K sh · $145.78K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 11.10M | 10.44M | 1.88M | 1.88M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.89M | 1.72M | 1.43M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 6.07M | 5.79M | 5.79M | 5.09M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.86M | 3.76M | 1.55M | 1.57M | 26.62K | 24.73K | 24.73K | 10.05K | — | — | 34.45K | 34.45K | 34.45K | 42.25K | — | — | 130.02K | 130.02K | 126.94K | 208.56K |
| FEDERATED HERMES, INC. | 3.14M | 3.14M | 3.14M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.93M | — | 636.20K | 644.00K | — | — | — | — | — | — | 22.46K | 22.46K | 22.46K | — | — | — | — | — | — | — |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.34M | — | — | 102.11K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 2.28M | 1.91M | 662.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Propel Bio Management, LLC | 2.22M | 2.58M | 1.11M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2.13M | 58.38K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 2.00M | 2.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.44M | 994.10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HighVista Strategies LLC | 1.15M | 2.03M | 2.02M | 1.30M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.12M | 885.91K | 659.29K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 1.08M | 737.31K | 1.17M | 247.75K | 19.41K | 332 | 38.08K | 8.97K | 31 | 1.22K | 2.23K | 2.52K | 108 | 108 | 1.34K | 4.12K | 100.63K | 21.50K | 8.11K | 3.83K |
| Creek Drive Management Group LLC | 680.00K | 440.00K | 540.00K | 307.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BIT Capital GmbH | 679.00K | 574.00K | 155.00K | 305.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 524.64K | 969.46K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 434.33K | 450.54K | 350.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 368.42K | 348.47K | 12.91K | 12.91K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PALI?
As of 2026-Q2, 129 institutional funds reported holding PALI (PALISADE BIO INC) in SEC 13F filings, with a combined reported value of $376.61M.
How many shares of PALI do institutions own?
13F filers reported 180.30M shares of PALI, worth $376.61M in aggregate at the end of 2026-Q2.
Is institutional ownership of PALI rising or falling?
Share counts moved +8.4% versus the prior quarter — accumulation.
Who are the top institutional holders of PALI?
The largest 13F holders are Soleus Capital Management, L.P., B Group, Inc., AMERIPRISE FINANCIAL INC, Jupiter Topco LLC, Octagon Capital Advisors LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of PALISADE BIO INC?
The major shareholders of PALISADE BIO INC (PALI) by reported 13F value are Soleus Capital Management, L.P., B Group, Inc., AMERIPRISE FINANCIAL INC, Jupiter Topco LLC, Octagon Capital Advisors LP, among 188 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.